These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 19356789)

  • 1. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
    Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
    BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
    Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
    Li J; Jia H; Xie L; Wang X; He H; Lin Y; Hu L
    Gynecol Oncol; 2009 Jul; 114(1):89-93. PubMed ID: 19359031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.
    Kodama J; Shinyo Y; Hasengaowa ; Kusumoto T; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Oncol Rep; 2005 Jul; 14(1):89-92. PubMed ID: 15944773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
    Yu W; Liu J; Xiong X; Ai Y; Wang H
    Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
    Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
    Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
    Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
    Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
    Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
    Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
    Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of EphB4 in head and neck squamous cell carcinoma.
    Sinha UK; Kundra A; Scalia P; Smith DL; Parsa B; Masood R; Gill PS
    Ear Nose Throat J; 2003 Nov; 82(11):866, 869-70, 887. PubMed ID: 14661437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.
    Kimura M; Kato Y; Sano D; Fujita K; Sakakibara A; Kondo N; Mikami Y; Tsukuda M
    Int J Oncol; 2009 Feb; 34(2):321-7. PubMed ID: 19148465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
    Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
    Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
    Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
    Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
    Wu SH; Zhang J; Li Y; Li JM
    Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.